AstraZeneca Pharma India Ltd on Monday reported over two-fold rise in profit after tax at Rs 53.86 crore for the first quarter ended June 30, 2023.

The company had posted a profit after tax of Rs 20.15 crore in the same quarter last fiscal, AstraZeneca Pharma India said in a regulatory filing.

Revenue from operations during the quarter under review stood at Rs 295.46 crore, as against Rs 232.33 crore in the year-ago period, it added.

Total expenses were higher at Rs 232.17 crore, as against Rs 209.14 crore, the company said.

Except for the headline, this story has not been edited by The Telegraph Online staff and has been published from a syndicated feed.